Compare ARK Genomic Revolution ETF (ARKG) vs Domino's Pizza, Inc. (DPZ) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ARK Genomic Revolution ETF vs Domino's Pizza, Inc. — how do they compare? ARK Genomic Revolution ETF trades at $41.24, while Domino's Pizza, Inc. trades at $300.01 (market cap $9.96B). The key difference: Domino's Pizza, Inc. pays a 2.66% dividend while ARK Genomic Revolution ETF pays none, and ARK Genomic Revolution ETF is trading nearer its 52-week high, Domino's Pizza, Inc. nearer its low. Which is the better fit depends on your goals.
| ARKG | DPZ | |
|---|---|---|
Sector | Sector/Thematic | Consumer Cyclical |
52-Week High | $43.57 | $485.53 |
52-Week Low | $23.09 | $282.89 |
Market Cap | — | $9.96B |
Enterprise Value | — | $14.86B |
Dividend Yield | — | 2.66% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
Domino's Pizza (DPZ) trades at $299.46, down 0.47% on the day, near its 52-week low. The stock shows a bearish technical signal with support at $297 and resistance at $304. Fundamentally, revenue grew to $4.94B in 2025 with a net income margin of 11.89%, though recent quarters have seen earnings misses. The company maintains strong profitability but faces headwinds from slowing US sales growth and a CEO transition announced in June 2026.
The outlook is mixed: analyst consensus is bullish with a $380.31 price target, but near-term risks include competitive pressures and macroeconomic challenges. Long-term investors may find value at current levels given the company's market dominance and digital capabilities, though execution under new leadership and sales recovery are critical for upside.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About Domino's Pizza, Inc.
Domino's is a restaurant operator and franchiser with nearly 19,000 global stores across more than 90 international markets at the end of 2021. The firm generates revenue through the sales of pizza, wings, salads, and sandwiches at company-owned stores, royalty and marketing contributions from franchise-operated stores, and its network of 25 domestic (and five Canadian) dough manufacturing and supply chain facilities, which centralize purchasing, preparation, and last-mile delivery for the firm's U.S. and Canadian restaurants. With roughly $17.7 billion in 2021 system sales, Domino's is the largest player in the global pizza market, ahead of Pizza Hut, Papa John's, and Little Caesars.
Read more on DPZ →
